Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftopidil for double-J ureteral stent discomfort
KCT0001194Phase 3Completed
- Sponsor
- Dong-A Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naftopidil in ureteral stent-related symptoms (USRS), sponsored by Dong-A Pharmaceutical. Started May 2014; status: completed.
02
Drugs
naftopidil
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on KCT0001194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001194.